HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1027191Generated: October 28, 2026
(Pyrrolidin-3-yl)methanol → 5-(1H-pyrazol-1-yl)-2-(6-(pyrrolidin-3-ylmethoxy)pyridazin-3-yl)phenol
https://huagongshe.com/reaction/1027191
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | (Pyrrolidin-3-yl)methanol | HCID 13400657 | — |
| Reactant | Potassium tert-butoxide | HCID 23665647 | — |
| Reactant | 2-(6-chloropyridazin-3-yl)-5-(1H-pyrazol-1-yl)phenol | HCID 136377141 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | 5-(1H-pyrazol-1-yl)-2-(6-(pyrrolidin-3-ylmethoxy)pyridazin-3-yl)phenol | HCID 136377144 | — |
Reaction Steps
Potassium tert-butoxide (1.0 M in THF, 0.7 mL, 0.7 mmol) was added to pyrrolidin-3-ylmethanol (0.06 g, 0.64 mmol) in THF (1.4 mL) and the mixture was stirred for 10 min at 50° C. 2-(6-Chloropyridazin-3-yl)-5-(1H-pyrazol-1-yl)phenol Intermediate 2-2 (0.05 g, 0.18 mmol) was added to the reaction at 0° C. and the mixture was stirred for 1 h at RT. Solvent was evaporated under reduced pressure. The crude material was purified via reverse phase preparative HPLC (5 to 95% acetonitrile in water, 5 mM NH4OH as modifier). Enantiomer 1 and Enantiomer 2 were isolated via preparative SFC. Two solids (11 mg (17%), and 12 mg (20%) were afforded.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08729263B2 |
|---|
| Source dataset | uspto-grants-2014_05 |
|---|
| ORD ID | ord-e6b232cb170244a1b640b3627c8b172d |
|---|
| Source note | uspto-grants-2014_05 |
|---|